当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2019年第20期
编号:13418325
胃癌患者外周血中性粒细胞及血小板与淋巴细胞比值与胃癌病理特征之间的关系(5)
http://www.100md.com 2019年7月15日 《中国医药导报》 2019年第20期
     [23] Sharaiha RZ,Halazun KJ,Mirza F,et al. Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer [J]. Ann Surg Oncol,2011,18(12):3362-3369.

    [24] Thavaramara T,Phaloprakarn C,Tangjitgamol S,et al. Role of neutrophil to lymphocyte ratio as a prognostic indicator for epithelial ovarian cancer [J]. J Med Assoc Thai,2011,94(7):871-877.

    [25] Azab B,Bhatt VR,Phookan J,et al. Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients [J]. Ann Surg Oncol,2012,19(1):217-224.

    [26] Wang SC,Chou JF,Strong VE,et al. Pretreatment Neutrophil to Lymphocyte Ratio Independently Predicts Disease-specific Survival in Resectable Gastroesophageal Junction and Gastric Adenocarcinoma [J]. Ann Surg,2016,263(2):292-297.

    [27] Aliustaoglu M,Bilici A,Ustaalioglu BB,et al. The effect of peripheral blood values on prognosis of patients with locally advanced gastric cancer before treatment [J]. Med Oncol,2010,27(4):1060-1065.

    [28] Ren G,Cai R,Zhang W,et al. Prediction of risk factors for lymph node metastasis in early gastric cancer [J]. World J Gastroenterol,2013,19(20):3096-3107.

    [29] Aizawa M,Gotohda N,Takahashi S,et al. Predictive value of baseline neutrophil/lymphocyte ratio for T4 disease in wall-penetrating gastric cancer [J]. World J Surg,2011,35(12):2717-2722., http://www.100md.com(刘珺良 王子文 费素娟)
上一页1 2 3 4 5